Get startedLog in
    Picture of Vanda Pharmaceuticals logo

    VNDA — Vanda Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    All News

    Brief: Vanda Pharmaceuticals Announces FDA Approval Of Nereus (Tradipitant)

    Picture of Vanda Pharmaceuticals logoVanda Pharmaceuticals
    30/12/2025 23:17
    Dec 30 (Reuters) - Vanda Pharmaceuticals Inc VNDA.O:

VANDA PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF NEREUS™ (TRADIPITANT) FOR THE PREVENTION OF VOMITING INDUCED BY MOTION: A HISTORIC SCIENTIFIC MILESTONE IN THE PREVENTION OF MOTION SICKNESS

Source text: ID:nPn5DR5hta

Further company coverage: VNDA.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Vanda Pharmaceuticals

    See all news